|
| Laura Mauri | Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply see Appendixes 1 and 2 for detailed information. ACC/AHA Representative. SCAI Representative. ACC/AHA Task Force on Clinical Practice Guidelines Liaison. Dr. Deborah D. Ascheim accepted a position at Capricor Therapeutics in August 5 |
| Roxana Mehran | Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply see Appendixes 1 and 2 for detailed information. ACC/AHA Representative. SCAI Representative. ACC/AHA Task Force on Clinical Practice Guidelines Liaison. Dr. Deborah D. Ascheim accepted a position at Capricor Therapeutics in August 5 |
| Issam Moussa | Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply see Appendixes 1 and 2 for detailed information. ACC/AHA Representative. SCAI Representative. ACC/AHA Task Force on Clinical Practice Guidelines Liaison. Dr. Deborah D. Ascheim accepted a position at Capricor Therapeutics in August 5 |
| Henry H Ting | Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply see Appendixes 1 and 2 for detailed information. ACC/AHA Representative. SCAI Representative. ACC/AHA Task Force on Clinical Practice Guidelines Liaison. Dr. Deborah D. Ascheim accepted a position at Capricor Therapeutics in August 5 |
| Ralph G Brindis | Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply see Appendixes 1 and 2 for detailed information. ACC/AHA Representative. SCAI Representative. ACC/AHA Task Force on Clinical Practice Guidelines Liaison. Dr. Deborah D. Ascheim accepted a position at Capricor Therapeutics in August 5 |
| Donald E Casey | Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply see Appendixes 1 and 2 for detailed information. ACC/AHA Representative. SCAI Representative. ACC/AHA Task Force on Clinical Practice Guidelines Liaison. Dr. Deborah D. Ascheim accepted a position at Capricor Therapeutics in August 5 |
| Deborah B Diercks | Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply see Appendixes 1 and 2 for detailed information. ACC/AHA Representative. SCAI Representative. ACC/AHA Task Force on Clinical Practice Guidelines Liaison. Dr. Deborah D. Ascheim accepted a position at Capricor Therapeutics in August 5 |
| Harlan M Krumholz | Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply see Appendixes 1 and 2 for detailed information. ACC/AHA Representative. SCAI Representative. ACC/AHA Task Force on Clinical Practice Guidelines Liaison. Dr. Deborah D. Ascheim accepted a position at Capricor Therapeutics in August 5 |
| Harlan M Krumholz | Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply see Appendixes 1 and 2 for detailed information. ACC/AHA Representative. SCAI Representative. ACC/AHA Task Force on Clinical Practice Guidelines Liaison. Dr. Deborah D. Ascheim accepted a position at Capricor Therapeutics in August 5 |
| David A Morrow | Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply see Appendixes 1 and 2 for detailed information. ACC/AHA Representative. SCAI Representative. ACC/AHA Task Force on Clinical Practice Guidelines Liaison. Dr. Deborah D. Ascheim accepted a position at Capricor Therapeutics in August 5 |
| David A Morrow | Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply see Appendixes 1 and 2 for detailed information. ACC/AHA Representative. SCAI Representative. ACC/AHA Task Force on Clinical Practice Guidelines Liaison. Dr. Deborah D. Ascheim accepted a position at Capricor Therapeutics in August 5 |
| Martha J Radford | Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply see Appendixes 1 and 2 for detailed information. ACC/AHA Representative. SCAI Representative. ACC/AHA Task Force on Clinical Practice Guidelines Liaison. Dr. Deborah D. Ascheim accepted a position at Capricor Therapeutics in August 5 |
| Yi-Ping Joseph Woo | Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply see Appendixes 1 and 2 for detailed information. ACC/AHA Representative. SCAI Representative. ACC/AHA Task Force on Clinical Practice Guidelines Liaison. Dr. Deborah D. Ascheim accepted a position at Capricor Therapeutics in August 5 |